Respirerx Pharmaceuticals Inc (RSPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,556 | 1,629 | 2,613 | 3,141 | 5,596 |
| Depreciation Amortization | 26 | 394 | 367 | 339 | 77 |
| Accounts receivable | N/A | N/A | N/A | N/A | -139 |
| Other Working Capital | 78 | -1,227 | -670 | -446 | 402 |
| Other Operating Activity | 12 | 542 | 500 | 444 | 261 |
| Operating Cash Flow | $-1,441 | $1,339 | $2,810 | $3,478 | $6,197 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,990 | -2,012 | -2,262 | -2,622 | N/A |
| PPE Investments | 3 | 13 | 13 | 8 | 34 |
| Investing Cash Flow | $1,993 | $-2,000 | $-2,250 | $-2,615 | $34 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 1,500 | 1,500 | 1,500 | 1,500 |
| Other Financing Activity | 0 | -28 | -28 | -28 | -28 |
| Financing Cash Flow | $N/A | $1,472 | $1,472 | $1,472 | $1,472 |
| Beginning Cash Position | 1,038 | 227 | 227 | 227 | 227 |
| End Cash Position | 1,589 | 1,038 | 2,259 | 2,562 | 7,929 |
| Net Cash Flow | $552 | $811 | $2,033 | $2,336 | $7,703 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,441 | 1,339 | 2,810 | 3,478 | 6,197 |
| Capital Expenditure | N/A | -51 | -51 | -56 | -24 |
| Free Cash Flow | -1,441 | 1,288 | 2,760 | 3,422 | 6,173 |